NANOPARTICLE DIAGNOSTIC AND METHODS FOR TREATING DISEASE

The present invention relates to the use of in vivo contrast agents in medical imaging in order to diagnose and treat disease, and to monitor and assess disease progression following treatment with a nanoparticle therapeutic agent comprising an active pharmaceutical agent. The present invention also...

Full description

Saved in:
Bibliographic Details
Main Authors Bilodeau, Mark T, Dupont, Michelle, Lim Soo, Patrick, Shinde, Rajesh R, Dunbar, Craig A, Iwicki, Mark, Kadiyala, Sudhakar, Alargova, Rossitza G
Format Patent
LanguageEnglish
Published 01.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the use of in vivo contrast agents in medical imaging in order to diagnose and treat disease, and to monitor and assess disease progression following treatment with a nanoparticle therapeutic agent comprising an active pharmaceutical agent. The present invention also relates to modulating nanoparticle tumor concentration by modulating the PEG density of the nanoparticles.
Bibliography:Application Number: US201916381332